The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
JOUNCE THERAPEUTICS, INC. | COM | 481116101 | 83,480 | 10,230,349 | SH | DFND | 1,2,3 | 10,230,349 | 0 | 0 | |
ALLENA PHARMACEUTICALS, INC. | COM | 018119107 | 4,131 | 2,790,964 | SH | DFND | 1,2,3 | 2,790,964 | 0 | 0 | |
REVOLUTION MEDICINES, INC. | COM | 76155X100 | 66,444 | 1,909,317 | SH | DFND | 1,2,3 | 1,909,317 | 0 | 0 |